Vanguard Group Inc Procept Bio Robotics Corp Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Vanguard Group Inc holds 4,843,351 shares of PRCT stock, worth $368 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,843,351
Previous 4,712,147
2.78%
Holding current value
$368 Million
Previous $288 Million
34.79%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding PRCT
# of Institutions
271Shares Held
38.7MCall Options Held
262KPut Options Held
257K-
Black Rock Inc. New York, NY3.49MShares$265 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.53MShares$117 Million0.04% of portfolio
-
Loomis Sayles & CO L P1.24MShares$94.5 Million0.13% of portfolio
-
State Street Corp Boston, MA1.18MShares$89.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$84.1 Million0.01% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $3.39B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...